CA2631024A1 - Derives de l'acide anthranilique utilisables pour le traitement d'une infection par le virus de l'hepatite c - Google Patents

Derives de l'acide anthranilique utilisables pour le traitement d'une infection par le virus de l'hepatite c Download PDF

Info

Publication number
CA2631024A1
CA2631024A1 CA002631024A CA2631024A CA2631024A1 CA 2631024 A1 CA2631024 A1 CA 2631024A1 CA 002631024 A CA002631024 A CA 002631024A CA 2631024 A CA2631024 A CA 2631024A CA 2631024 A1 CA2631024 A1 CA 2631024A1
Authority
CA
Canada
Prior art keywords
acetyl
amino
benzoic acid
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002631024A
Other languages
English (en)
Inventor
Jonathan David Bloom
Shabana Insaf
Thomas Nittoli
Alan Gordon Sutherland
Kevin J. Curran
Karen Wheless
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth
Jonathan David Bloom
Shabana Insaf
Thomas Nittoli
Alan Gordon Sutherland
Kevin J. Curran
Karen Wheless
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth, Jonathan David Bloom, Shabana Insaf, Thomas Nittoli, Alan Gordon Sutherland, Kevin J. Curran, Karen Wheless filed Critical Wyeth
Publication of CA2631024A1 publication Critical patent/CA2631024A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
CA002631024A 2005-12-01 2006-12-01 Derives de l'acide anthranilique utilisables pour le traitement d'une infection par le virus de l'hepatite c Abandoned CA2631024A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74177205P 2005-12-01 2005-12-01
US60/741,772 2005-12-01
PCT/US2006/045950 WO2008051244A2 (fr) 2005-12-01 2006-12-01 Dérivés de l'acide anthranilique utilisables pour le traitement d'une infection par le virus de l'hépatite c

Publications (1)

Publication Number Publication Date
CA2631024A1 true CA2631024A1 (fr) 2008-05-02

Family

ID=39273567

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002631024A Abandoned CA2631024A1 (fr) 2005-12-01 2006-12-01 Derives de l'acide anthranilique utilisables pour le traitement d'une infection par le virus de l'hepatite c

Country Status (7)

Country Link
EP (1) EP1966181A2 (fr)
JP (1) JP2009519240A (fr)
CN (1) CN101336236A (fr)
AU (1) AU2006349612A1 (fr)
BR (1) BRPI0619132A2 (fr)
CA (1) CA2631024A1 (fr)
WO (1) WO2008051244A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS55462B1 (sr) * 2011-08-19 2017-04-28 Glaxo Group Ltd Jedinjenja benzofurana za tretiranje infekcija sa virusom hepatitisa c

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003304040A1 (en) * 2002-10-08 2004-11-04 Viropharma Incorporated Anthranilic acid derivatives useful in treating infection with hepatitis c virus

Also Published As

Publication number Publication date
AU2006349612A1 (en) 2008-05-02
JP2009519240A (ja) 2009-05-14
CN101336236A (zh) 2008-12-31
WO2008051244A3 (fr) 2008-07-17
BRPI0619132A2 (pt) 2011-09-13
EP1966181A2 (fr) 2008-09-10
WO2008051244A2 (fr) 2008-05-02

Similar Documents

Publication Publication Date Title
US7250441B2 (en) Carbazole and cyclopentaindole derivatives to treat infection with Hepatitis C virus
EP1321463B1 (fr) Dérivés de thiazole et leur utilisation dans le traitement ou la prévention d'infections par des Flavivirus
US6964979B2 (en) R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
JP2007526320A (ja) ピラノインドール誘導体およびｃ型肝炎ウイルス感染症または疾患の治療のためのその使用
KR20070083484A (ko) Ｃ형 간염 치료 방법
WO2008029168A2 (fr) Traitement de la dystrophie musculaire de duchenne
US7217730B2 (en) Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus
CA2631024A1 (fr) Derives de l'acide anthranilique utilisables pour le traitement d'une infection par le virus de l'hepatite c
US20080269333A1 (en) Anthranilic acid derivatives useful in treating infection with hepatitis c virus
US20070276030A1 (en) Pyranobenzothiophene derivatives to treat infection with hepatitis c virus
MX2008007081A (en) Anthranilic acid derivatives useful in treating infection with hepatitis c virus
JP2022512873A (ja) Ｂ型肝炎ウイルス（ｈｂｖ）に対して活性を有する新規尿素６，７－ジヒドロ－４ｈ－ピラゾロ［４，３－ｃ］ピリジン
KR101567558B1 (ko) Ｃ형 간염 바이러스의 게놈 복제의 선택적 저해 활성을 갖는 인돌계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 ｃ형 간염의 예방 또는 치료용 약학적 조성물
AU2014297912A1 (en) Novel indazole compounds and a process for the preparation thereof

Legal Events

Date Code Title Description
FZDE Dead